On 9 November 2019, members of the International Relapsing Polychondritis Research Network (IRPRN) met at The American Hotel in Atlanta, GA to (1) provide an update on the relapsing polychondritis (RP) classification criteria project, (2) introduce a new project to modify the RP disease activity index, and (3) discuss ongoing and recently completed RP-related projects.
Thank you to the highly skilled, collaborative, global experts — with a broad range of specialties and disciplines — for meeting to advance research to facilitate treatments and a cure for RP.
The RP Foundation and the Race for RP were most pleased to facilitate the IRPRN meeting and look forward to supporting future collaborative meetings that benefit the RP and autoimmune disease communities.
The World of Relapsing Polychondritis
Relapsing Polychondritis Patients Need Earlier Diagnosis, Effective Treatments and Disease Awareness
Expert doctors, relapsing polychondritis (RP) patients, and advocates explain the need for new treatments and the importance of accelerating research on RP, a debilitating systemic inflammatory disease that is characterized by recurrent inflammation of cartilage and other tissues throughout the body.